NAMI
BBIO icon

Nomura Asset Management International’s BridgeBio Pharma BBIO Stock Holding History

Nomura Asset Management International’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.8M Sell
829,802
-704,934
-46% -$49.4M 0.09% 292
2026
Q1 		$114M Sell
1,534,736
-190,530
-11% -$13.8M 0.2% 109
2025
Q4 		$132M Buy
+1,725,266
New +$113M 0.2% 116

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Nomura Asset Management International's BBIO Position: Q2 2026 in Review

Nomura Asset Management International reduced its BridgeBio Pharma (BBIO) stake by 46% in Q2 2026, selling an estimated $49.4M and leaving 829,802 shares worth $61.8M. The position accounts for 0.09% of the portfolio, ranked #292.

Nomura Asset Management International first reported a position in BBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $132M in Q4 2025. 471 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Nomura Asset Management International held 829,802 shares of BridgeBio Pharma worth $61.8M as of Q2 2026.
  • Nomura Asset Management International sold 704,934 BridgeBio Pharma shares in Q2 2026, an estimated $49.4M.
  • BridgeBio Pharma made up 0.09% of Nomura Asset Management International's portfolio in Q2 2026, its #292 holding.
  • Nomura Asset Management International first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's BridgeBio Pharma position peaked at $132M in Q4 2025.
  • 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.